Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
OneWater Marine Inc. Announces Fiscal Fourth Quarter and Full-Year 2024 Earnings Release Date and Conference Call Information
-
Thetis Pharmaceuticals Announces Positive Initial Results From Phase 1a Study of TP-317 in Healthy Subjects
-
FIRST MINING SIGNS PROCESS AGREEMENT WITH CAT LAKE FIRST NATION AND LAC SEUL FIRST NATION SUPPORTING ANISHINAABE-LED IMPACT ASSESSMENT
-
Breckenridge Brewery and University of Colorado Athletics Collaborate on New Limited-Edition Craft Beer
-
Aduro Clean Technologies Reports Fiscal 2025 First Quarter Results
-
Ventus Therapeutics Announces Successful Completion of Phase 1 Clinical Trial of VENT-03, a First-in-Class, Orally Administered cGAS Inhibitor
-
Thumzup Reveals Plans for Significant Advertiser Growth Over the Next Year
-
Cipher Mining Provides Third Quarter 2024 Business Update
-
Travere Therapeutics Reports Third Quarter 2024 Financial Results
-
Bombardier Celebrates 100th Challenger 3500 Aircraft Delivery, Underscoring Continued Success as Best-Selling Platform
-
Peloton Appoints Peter Stern as CEO and President
-
Largo to Release its Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
-
Macerich Declares the Quarterly Dividend on Its Common Shares
-
BIG3 and Sport Trinity Announce Settlement, Celebrate Renewed Commitment to Basketball Community
-
Bitfarms Enters into Second 10,000 Miner Hosting Agreement with Stronghold Digital Mining
-
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024
-
Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results
-
ENGIE and Meta announce 260 MW renewable energy agreement
-
Sandy Spring Bancorp Declares Quarterly Dividend
-
We should all ditch the clocks, or at the very least Daylight Saving: York University expert
-
C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program
-
Malibu Boats, Inc. Announces First Quarter Fiscal 2025 Results
-
SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference
-
Climb Bio to Present at Upcoming Investor Conferences
-
PyroGenesis Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
-
GXO Releases 2024 Global Beauty Report
-
BostonGene to Showcase Innovative Precision Medicine Strategies for Non-Small Cell Lung Cancer at the Advancing Precision Medicine Conference 2024
-
BRT Apartments Corp. Announces Filing Date for Third Quarter 2024 Earnings Results
-
Total voting rights
-
OTC Markets Group Welcomes Brazilian Rare Earths Ltd. to OTCQX
-
Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024
-
Bristol Myers Squibb Reports Third Quarter Financial Results for 2024
-
Study Finds New Digital Products Offer Billions in Revenue Potential by Helping Protect Elderly from Fraud
-
Zoomlion Brings Latest Innovative Agricultural Solutions to 2024 China International Agricultural Machinery Exhibition
-
Xylem Reports Third Quarter 2024 Results and Narrows Full-Year Guidance
-
Uber Announces Results for Third Quarter 2024
-
Green Plains Reports Third Quarter 2024 Financial Results
-
Trinity Industries, Inc. Announces Third Quarter 2024 Results
-
Hyatt Reports Third Quarter 2024 Results
-
Ryder Receives Supplier-of-the-Year Award from Toyota
-
QUANTA SERVICES REPORTS THIRD QUARTER 2024 RESULTS
-
AMETEK Announces Third Quarter Results
-
AMETEK Acquires Virtek Vision International
-
AECOM selected for a $90 million single-award task order for the G7 Partnership for Global Infrastructure and Investment
-
SunCoke Energy, Inc. Declares Cash Dividend
-
Man Group PLC : Form 8.3 - TI Fluid Systems plc
-
Man Group PLC : Form 8.3 - International Paper Company
-
HSBC Bank PLC: Pre Stabilisation Notice
-
Kontoor Brands Reports 2024 Third Quarter Results; Raises Full Year Outlook

